Literature DB >> 23566044

PAX6 mutation in association with ptosis, cataract, iris hypoplasia, corneal opacification and diabetes: a new variant of familial aniridia?

Neena M Peter1, Martin Leyland, Hardeep S Mudhar, Jo Lowndes, Katharine R Owen, Helen Stewart.   

Abstract

BACKGROUND: We report a family with ptosis, cataract, iris hypoplasia and gradual corneal opacification occurring in association with a PAX6 mutation.
DESIGN: Case-series. PARTICIPANTS: Fourteen family members - 8 affected, 6 unaffected controls.
METHODS: All participants underwent ophthalmological assessment, including best-corrected visual acuity, slit-lamp-examination, pachymetry, endothelial cell-count, tonometry and dilated fundoscopy. All subjects underwent anthropometry and assessment of glycaemic status. Genetic analysis of the PAX6 gene was performed. MAIN OUTCOME MEASURES: Presence of ptosis, corneal, iris and lenticular changes, gycaemic and PAX6 status.
RESULTS: All eight affected subjects had ptosis with reduced levator function, anterior polar cataracts, and corneal changes of variable severity - two patients had undergone penetrating keratoplasties, with graft histology revealing conjunctival cells on the cornea and severe fibroinflammatory change. Five patients had iris hypoplasia. One patient had aphakic glaucoma and another had hypoplastic optic discs. Four of the six controls had no ocular features of this syndrome, and two had isolated mild ptosis. There was no difference in height or body mass index between cases and family controls (p > 0.05), but Haemoglobin A1c was greater in the cases (median [interquartile range] 5.6(0.8) vs 5.1(0.3), p = 0.028). Genetic analysis confirmed a pathogenic PAX6 mutation in exon 12 (c1439delC) in all eight patients, but none of the controls.
CONCLUSION: This is the first report of this particular constellation of ocular signs occurring in association with a PAX6 mutation. There was no association with anthropometric features, but affected subjects had worse glycaemia than controls, which may be related to the known role of PAX6 in development of the pancreas.
© 2013 The Authors. Clinical and Experimental Ophthalmology © 2013 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  PAX6; aniridia-related keratopathy; cataract; diabetes; ptosis

Mesh:

Substances:

Year:  2013        PMID: 23566044     DOI: 10.1111/ceo.12109

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  10 in total

1.  [Aniridia syndrome: clinical findings, problematic courses and suggestions for optimization of care ("aniridia guide")].

Authors:  B Käsmann-Kellner; B Seitz
Journal:  Ophthalmologe       Date:  2014-12       Impact factor: 1.059

2.  PAX6 maintains β cell identity by repressing genes of alternative islet cell types.

Authors:  Avital Swisa; Dana Avrahami; Noa Eden; Jia Zhang; Eseye Feleke; Tehila Dahan; Yamit Cohen-Tayar; Miri Stolovich-Rain; Klaus H Kaestner; Benjamin Glaser; Ruth Ashery-Padan; Yuval Dor
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

3.  Assessment of PAX6 alleles in 66 families with aniridia.

Authors:  A M Bobilev; M E McDougal; W L Taylor; E E Geisert; P A Netland; J D Lauderdale
Journal:  Clin Genet       Date:  2016-01-25       Impact factor: 4.438

4.  Congenital aniridia: etiology, manifestations and management.

Authors:  Monica Samant; Bharesh K Chauhan; Kira L Lathrop; Ken K Nischal
Journal:  Expert Rev Ophthalmol       Date:  2016-03-09

5.  Sporadic and Familial Congenital Cataracts: Mutational Spectrum and New Diagnoses Using Next-Generation Sequencing.

Authors:  Alan S Ma; John R Grigg; Gladys Ho; Ivan Prokudin; Elizabeth Farnsworth; Katherine Holman; Anson Cheng; Frank A Billson; Frank Martin; Clare Fraser; David Mowat; James Smith; John Christodoulou; Maree Flaherty; Bruce Bennetts; Robyn V Jamieson
Journal:  Hum Mutat       Date:  2016-01-14       Impact factor: 4.878

6.  Genome-wide analysis suggests a differential microRNA signature associated with normal and diabetic human corneal limbus.

Authors:  Mangesh Kulkarni; Aleksandra Leszczynska; Gabbie Wei; Michael A Winkler; Jie Tang; Vincent A Funari; Nan Deng; Zhenqiu Liu; Vasu Punj; Sophie X Deng; Alexander V Ljubimov; Mehrnoosh Saghizadeh
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

7.  A novel 4.25 kb heterozygous deletion in PAX6 in a Chinese Han family with congenital aniridia combined with cataract and nystagmus.

Authors:  Tianwei Qian; Chong Chen; Caihua Li; Qiaoyun Gong; Kun Liu; Gao Wang; Isabelle Schrauwen; Xun Xu
Journal:  BMC Ophthalmol       Date:  2021-10-05       Impact factor: 2.209

Review 8.  Clinical and molecular aspects of congenital aniridia - A review of current concepts.

Authors:  Shailja Tibrewal; Ria Ratna; Abha Gour; Sumita Agarkar; Suneeta Dubey; Suma Ganesh; Ramesh Kekunnaya; Virender Sangwan; Yutao Liu; Vanita Vanita
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

9.  Protecting Pax6 3' UTR from MicroRNA-7 Partially Restores PAX6 in Islets from an Aniridia Mouse Model.

Authors:  Kevin Yongblah; Spencer C Alford; Bridget C Ryan; Robert L Chow; Perry L Howard
Journal:  Mol Ther Nucleic Acids       Date:  2018-09-01       Impact factor: 8.886

10.  Longitudinal genotype-phenotype analysis in 86 patients with PAX6-related aniridia.

Authors:  Vivienne Kit; Dulce Lima Cunha; Ahmed M Hagag; Mariya Moosajee
Journal:  JCI Insight       Date:  2021-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.